Thanks to His Research Hepatitis C is Now Curable
Award of the Hector Stiftung goes to Prof. Dr. Ralf Bartenschlager from Heidelberg
HEIDELBERG/WEINHEIM. Prof. Dr. Ralf Bartenschlager (University of Heidelberg) received the Hector Science Award of the Hector Stiftung for his great achievements in the medical fundamental research. Thanks to his work with hepatitis C, more than 95 percent of the patients are curable. Furthermore, his team has highly contributed to the research of the dengue fever, the world’s most infectious mosquito-borne disease.
Theresia Bauer emphasized in the laudation for Prof. Dr. Bartenschlager, besides his high scientific performance, the positive impact he has on the students for fundamental research.
In 1999, Prof. Dr. Bartenschlager achieved replicating the hepatitis C virus in a laboratory. This was a crucial success in the research of the virus, since now his team was able to study the factors of the reproduction of the hepatitis C virus and determine which substances inhibit the reproduction cycle. His current focus lies in the development of a vaccine for hepatitis C. Besides this, his work led to new findings about chronical infections with other viruses like the hepatitis B virus.
In May 2020, an interdisciplinary Hector Workshop will bring Quantum Matter researchers together.
On October 1, Peter Gumbsch was appointed chairman of the Fraunhofer Group MATERIALS.
Hector Fellowto the news overview